| Availability Dates |
Title |
Credit Hours |
|
June 1, 2021 12:00 AM - June 1, 2022 11:59 PM
|
Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking
|
0.75 |
|
June 15, 2021 12:00 AM - June 15, 2022 11:59 PM
|
CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis
|
3.00 |
|
August 1, 2021 12:00 AM - August 1, 2022 11:59 PM
|
Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research
|
0.75 |
|
September 15, 2021 7:45 PM - October 31, 2022 11:59 PM
|
Managing Multiple Sclerosis: A Team Approach
Session 1: The Nature of MS and the Role of the Team
|
1.00 |
|
September 22, 2021 7:45 PM - October 31, 2022 12:00 AM
|
Managing Multiple Sclerosis: A Team Approach
Session 2: Spasticity and Mobility in MS
|
1.00 |
|
September 29, 2021 8:00 PM - October 31, 2022 11:59 PM
|
Managing Multiple Sclerosis: A Team Approach
Session 3: Balance, Motor, and Neuroplasticity in MS
|
1.00 |
|
October 1, 2021 12:00 AM - October 31, 2022 11:59 PM
|
Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic
|
0.50 |
|
October 6, 2021 7:45 PM - October 31, 2022 11:59 PM
|
Managing Multiple Sclerosis: A Team Approach
Session 4: Fatigue and Cognitive Impairment in MS
|
1.00 |
|
October 12, 2021 12:00 AM - October 31, 2022 11:59 PM
|
Managing Multiple Sclerosis: A Team Approach
Session 5: Communication, Swallowing and Case Review
|
1.00 |
|
October 31, 2021 12:00 AM - October 31, 2022 11:59 PM
|
CANNABIS AND MS: FUNDAMENTALS OF CANNABIS
|
1.00 |
|
October 31, 2021 12:00 AM - October 31, 2022 11:59 PM
|
CANNABIS AND MS: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES
|
1.00 |
|
October 31, 2021 12:00 AM - October 31, 2022 12:00 AM
|
CANNABIS AND MS: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, CASE STUDIES
|
1.00 |
|
December 1, 2021 12:00 AM - December 31, 2022 11:59 PM
|
NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights
|
1.00 |
|
February 1, 2022 12:00 AM - January 31, 2024 11:59 PM
|
Fundamentals of Multiple Sclerosis Care
Part 1: Diagnosing the Disease and Managing Specific Populations
|
2.75 |
|
February 1, 2022 12:00 AM - January 31, 2024 11:59 PM
|
Fundamentals of Multiple Sclerosis Care
Part 2: Diagnosing the Disease and Managing Specific Populations
|
2.25 |
|
February 1, 2022 12:00 AM - January 31, 2024 11:59 PM
|
Fundamentals of Multiple Sclerosis Care
Part 3: Current and Emerging Therapies and Symptom Management
|
2.50 |
|
February 1, 2022 12:00 AM - January 31, 2024 11:59 PM
|
Fundamentals of Multiple Sclerosis Care
Part 4: Current and Emerging Therapies and Symptom Management
|
2.50 |
|
February 1, 2022 12:00 AM - February 1, 2023 11:59 PM
|
Recommendations to Address the Unique Clinical and Psychological Needs of Transgender Persons Living with Multiple Sclerosis
|
0.50 |
|
April 1, 2022 12:00 AM - April 1, 2023 11:59 PM
|
Characteristics of Prescription Drug Use Among Individuals with Multiple Sclerosis in the US Medicare Population
|
0.50 |
|
May 1, 2022 12:00 AM - May 31, 2023 11:59 PM
|
The Impact of COVID-19 on the Lives of People With Multiple Sclerosis: 1 Year Into the Pandemic
|
0.50 |
| Back To Top |
